Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone: Results of Three Multicentre Trials

Author： Bitzer Johannes  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.29, Iss.2, 2009-01, pp. : 73-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-dose ethinylestradiol/drospirenone effective oral contraceptive

By  

Inpharma, Vol. 1, Iss. 1535, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20µg and Drospirenone 3mg

By Cibula D.  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 143-150

Adis International

Access to resources Recommend Favorite

Six-Month Evaluation of the Benefits of the Low-Dose Combined Oral Contraceptive Chlormadinone Acetate 2 mg/Ethinylestradiol 0.03 mg in Young Women: Results of the Prospective, Observational, Non-Interventional, Multicentre TeeNIS Study

By Anthuber Sabine  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 211-220

Adis International

Access to resources Recommend Favorite

Safety of a New Oral Contraceptive Containing Drospirenone

By Lothar A.J. Heinemann  

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 1001-1018

Adis International

Access to resources Recommend Favorite

User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice: A Multi-Country, Questionnaire-Based Study

By Short Mary  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 153-159

Adis International

Access to resources Recommend Favorite